Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Registration - 2007

FR Doc E7-4825 [Federal Register: March 16, 2007 (Volume 72, Number 51)] [Notices] [Page 12635] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr16mr07-94]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated July 26, 2006, and published in the Federal Register on August 2, 2006, (71 FR 43814-43815), Siegfried (USA), Inc., Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II:

Drug Schedule
Amphetamine (1100)  II
Methylphenidate (1724)  II
Amobarbital (2125)  II
Pentobarbital (2270)  II
Secobarbital (2315)  II
Glutethimide (2550)  II
Codeine (9050)  II
Oxycodone (9143)  II
Hydrocodone (9193)  II
Methadone (9250)  II
Methadone intermediate (9254)  II
Dextropropoxyphene, bulk (non-dosage forms) (9273)  II
Morphine (9300)  II

The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.

Siegfried (USA) Inc.'s application for renewal requested that DEA add Hydromorphone (9150) to its registration. DEA is reviewing this request. DEA's granting of Siegfried (USA) Inc.'s application for renewal does not include the authority to handle Hydromorphone (9150). When DEA has completed its review of the firm's request to add Hydromorphone (9150) to its registration, DEA will publish its decision in the Federal Register.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Siegfried (USA), Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Siegfried (USA), Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: March 9, 2007.

Joseph T. Rannazzisi, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. E7-4825 Filed 3-15-07; 8:45 am]

BILLING CODE 4410-09-P

 

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility